Diabetes Obes Metab (2011) 13:42633
Do you want to lose weight or improve your blood sugar control
Here are some key considerations: 1
Data from pregnancies occurring during clinical development, hospital-based databases, and the European Medicines Agencys semaglutide pregnancy registry have not shown an increased rate of major congenital anomalies but all analyses to date were severely underpowered due to small sample sizes
I think there is some potential benefit, one physician said, but I would like to see the long term data of how to keep these gains. According to another physician, more long term research is needed
Other additions to Category 1 include ruxolitinib phosphate, a JAK1and JAK2 inhibitor currently commercially available orally and topically for conditions such as myelofibrosis or atopic dermatitis respectively and dimercaprol,a chelating drug currently commercially-available as an injectable